Consun Pharma Schedules 26 May 2026 AGM, Proposes HKD0.40 Final Dividend and New Share Mandates

Bulletin Express
04/28

Consun Pharmaceutical Group Limited (“Consun Pharma”) has issued a circular convening its 2026 annual general meeting (AGM) for 26 May 2026 at 10:00 a.m., to be held both physically in Hong Kong and via online platform. Key resolutions to be put before shareholders are summarised below.

Dividend Proposal • Board recommends a final dividend of HKD0.40 per share for FY 2025. • Subject to approval, the dividend is expected to be paid on or about 22 June 2026 to shareholders on record as at 10 June 2026.

Board Composition • Executive Chairman & CEO Mr An Meng, Independent Non-executive Directors Professor Li Yikai and Mr Duan Weiwu will retire by rotation and seek re-election. • The nomination committee has affirmed the independence of the two independent directors in accordance with Rule 3.13 of the Listing Rules.

Auditor Appointment • Re-appointment of KPMG as external auditor for FY 2026 is proposed. • Agreed fees: RMB2.60 million for audit services and RMB0.50 million for non-audit work, unchanged from the previous year.

General Mandates • Issuing Mandate: authority to allot and issue new shares up to 20% of issued share capital on the AGM date. • Repurchase Mandate: authority to repurchase up to 10% of issued shares (maximum 84.15 million shares based on 841.55 million shares outstanding at the latest practicable date). • Extension Mandate: number of shares repurchased under the Repurchase Mandate may be added to the Issuing Mandate.

Share Capital and Recent Buy-backs • Shares in issue as at the latest practicable date: 841.55 million. • The company repurchased 8.49 million shares on-market between 14 October 2025 and 6 January 2026 for a total consideration of HKD126.81 million.

Key Dates • Register closure for AGM voting: 20–26 May 2026 (both days inclusive). • Deadline for form of proxy: 48 hours before the AGM. • Record date for dividend entitlement: 10 June 2026.

Shareholders may attend the AGM in person or via the designated online platform and are urged to submit proxy forms in advance if unable to participate. All AGM resolutions will be decided by poll.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10